A clinical formulation indicated for Thyroid Health. Promotes the stabilization of thyroid hormone production to manage the physiological symptoms of hyperthyroidism.
Designed to mitigate overactive thyroid hormone levels to address hyperthyroidism symptoms and alleviate strain on metabolism and heart function in adult patients.
Mechanism of Action
Carbimazole is converted to methimazole in the body. It blocks the enzyme responsible for making thyroid hormones, effectively reducing the excess levels that cause symptoms like rapid heart rate and weight loss.
Route of Administration
Oral
Onset Time
1–3 weeks
Duration
12–24 hours
Contraindications
Severe blood disorders, Severe liver impairment, History of pancreatitis from carbimazole, Hypersensitivity
Severe Adverse Events
Agranulocytosis (Severe white cell loss), Liver failure, Acute pancreatitis, Bone marrow suppression, Severe skin reactions
Common Side Effects
Nausea, Mild rash
Uncommon Side Effects
Joint pain, Headache, Itching, Fever, Hair loss, Changes in taste
Drug Interactions
Warfarin, Digoxin, Theophylline, Beta-blockers
Pregnancy Safety Warnings
Use lowest effective dose if necessary; methimazole can cause fetal harm.
Information for NeoMercazole is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
